Company Overview and News

 
DESPATCH OF COMPOSITE DOCUMENT

2017-07-28 londonstockexchange
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this joint announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this joint announcement.

 
Further re share exchange offer

2017-07-07 londonstockexchange
Reference is made to the joint announcement of S E A Holdings Limited ("SEA") and Nan Luen International Limited (the "Offeror") dated 31 March 2017 in relation to, among other things, the Share Exchange Offer (the "Joint Announcement"), the joint announcement of SEA and the Offeror dated 18 April 2017 in relation to the revised timetable and the joint announcements of the Offeror and Asian Growth Properties Limited ("AGP") dated 5 May 2017, 17 May 2017, 5 June 2017 and 16 June 2017 in relation to the delay in despatch of the Composite Document.

 
Further re share exchange offer

2017-06-16 londonstockexchange
Reference is made to the joint announcement of S E A Holdings Limited ("SEA") and Nan Luen International Limited (the "Offeror") dated 31 March 2017 in relation to, among other things, the Share Exchange Offer (the "Joint Announcement"), the joint announcement of SEA and the Offeror dated 18 April 2017 in relation to the revised timetable and the joint announcements of the Offeror and Asian Growth Properties Limited ("AGP") dated 5 May 2017, 17 May 2017 and 5 June 2017 in relation to the delay in despatch of the Composite Document.

 
Further re share exchange offer

2017-06-05 londonstockexchange
Reference is made to the joint announcement of S E A Holdings Limited ("SEA") and Nan Luen International  Limited (the "Offeror") dated 31 March 2017 in relation to, among other things, the Share Exchange Offer ("Joint Announcement"), the joint announcement of SEA and the Offeror dated 18 April 2017 in relation to the revised timetable and the joint announcements of the Offeror and Asian Growth Properties Limited ("AGP") dated 5 May 2017 and 17 May 2017 in relation to the delay in despatch of the Composite Document.

 
Further re share exchange offer

2017-05-17 londonstockexchange
Reference is made to the joint announcement of S E A Holdings Limited ("SEA") and Nan Luen International Limited (the "Offeror") dated 31 March 2017 in relation to, among other things, the Share Exchange Offer (the "Joint Announcement"), the joint announcement of SEA and the Offeror dated 18 April 2017 in relation to the revised timetable and the joint announcement of the Offeror and Asian Growth Properties Limited ("AGP") dated 5 May 2017 in relation to the delay in despatch of the Composite Document (the "Delay in Despatch Announcement"), and the announcements of SEA and AGP dated 15 May 2017 in relation to, among other things, completion of the SP Agreement and the Distribution in Specie (the "Completion of Distribution Announcement").

 
Completion of SP Agreement, Distribution in Specie

2017-05-15 londonstockexchange
Reference is made to the circular (the "Circular") of Asian Growth Properties Limited (the "Company", together with its subsidiaries, the "Group") (AIM Stock Code: AGP), the Hong Kong based China property development and investment company, dated 31 March 2017 and the announcements of the Company dated 31 March 2017, 11 April 2017, 18 April 2017, 21 April 2017 and 4 May 2017 (the "Announcements"). Unless otherwise defined, the capitalised terms used in this announcement shall have the same meaning as those defined in the Circular.

 
Further re Proposed Disposal of Assets

2017-05-05 londonstockexchange
Reference is made to the joint announcement of S E A Holdings Limited ("SEA") and Nan Luen International Limited (the "Offeror") dated 31 March 2017 in relation to, among other things, the Share Exchange Offer ("Joint Announcement") and the joint announcement of SEA and the Offeror dated 18 April 2017 in relation to the revised timetable (the "Revised Timetable Announcement"). Unless the context otherwise requires, capitalised terms used herein shall bear the same meanings as defined in the Joint Announcement.

 
Result of Special General Meeting

2017-04-21 londonstockexchange
Reference is made to a Special General Meeting (the "SGM") convened by Asian Growth Properties Limited (the "Company" or "AGP") (AIM Stock Code: AGP), the Hong Kong based China property development and investment company, on 21 April 2017 for the purpose of considering and passing ordinary resolutions regarding the proposed disposal by the Company of certain of its assets to S E A Holdings Limited and the proposed special dividend as set out in the notice of SGM dated 31 March 2017.

 
Further re Proposed Disposal of Assets

2017-04-11 londonstockexchange
AGP notes the following announcement released by S E A Holdings Limited ("SEA")" on 10 April 2017 as set out below.

 
Further re Share Exchange Offer

2017-04-05 londonstockexchange
The Board was informed by the Offeror that the Offeror would make a voluntary Share Exchange Offer to the Company.

 
Proposed Disposal of Assets

2017-04-03 londonstockexchange
·    the entry into a conditional sale agreement with its majority shareholder SEA in relation to the sale of the Company's Non-PRC Assets to SEA at an aggregate price of HK$8,913,354,000 (£913,637,286); and 

 
Final Results

2017-03-17 londonstockexchange
Asian Growth Properties Limited (the "Company") (AIM Stock Code: AGP), the Hong Kong based China property development and investment company, announces its audited consolidated results for the year ended 31 December 2016 as follows:

 
City of London Acquisition

2016-11-07 londonstockexchange
The Company is pleased to announce that on 7 November 2016, the Buyers (both of which are indirect wholly-owned subsidiaries of AGP) purchased from the Sellers the entire issued Units in the Trust that owns the Property known as 20 Moorgate, London, EC2R 6DA, pursuant to the terms of the S&P Agreement for a total consideration of approximately £154 million (approximately HK$1,491.0 million) (before the Buyers' transaction costs and expenses).

 
Director/PDMR Shareholding

2016-09-02 londonstockexchange
The board of directors of Asian Growth Properties Limited (the "Company") (AIM Stock Code: AGP), the Hong Kong based China property development and investment company, announces that the Company has today received notifications from the following directors of the Company reporting their respective deemed interests in the ordinary shares of US$0.05 each in the Company (the "Shares") as follows:

 
Disposal

2016-08-22 londonstockexchange
The Company is pleased to announce that the Vendor (a direct wholly-owned subsidiary of AGP) has entered into the Sale Agreement with the Purchaser in relation to the conditional Disposal to the Purchaser of the Target Group, which owns the Land under development in Chengdu, Sichuan Province, the PRC, for the Consideration (for the Sale Share and the Shareholder's Loan) of HK$890 million (approximately £87.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...